SetPoint Medical

It’s official! #SetPointSystem is now FDA approved for the treatment of rheumatoid arthritis (RA) in adults who are not adequately managed by, or who cannot tolerate, existing advanced RA therapies. See the release: setpointmedical.com/setpoint-medic… #Rheumatology #RheumTwitter #MedTwitter

The first #SetPointSystem procedure in California was just preformed at @DignityHealth - St. John's Regional Medical Center! Congrats to Dr. Gita Fatemi, Dr. Akinwunmi Oni-Orisan and SJRMC teams. Get the full story: dignityhealth.org/central-coast/… Safety Info: spm.care/ISI

The #SetPointSystem has arrived in Texas. We're proud to announce the first SetPoint System procedure in the state, performed by Peterson at @Ascensionorg Dell Seton Medical Center at The University of Texas. Safety info: spm.care/ISI setpointmedical.com/first-setpoint…

Thank you to study authors Drs. Jeffrey Curtis, Shilpa Venkatachalam & Josh Baker, as well as Sherry Danese, Julie Ulloa and the whole research team involved in this important work. Full study (open access) → pmc.ncbi.nlm.nih.gov/articles/PMC12… #MedEd #RheumatoidArthritis #StartActivating

Only 32% reported being satisfied with their current treatment. 48% would prefer neuroimmune modulation device after experience with first biologic, higher compared to starting JAK inhibitors or another TNF inhibitor. #RheumTwitter #Rheumatology #RAWarrior

Shared decision-making is a core @ACRheum recommendation for RA management — meaning treatment decisions should reflect what matters most to each patient. New peer-reviewed research explores exactly that. 🧵

Big news: Our landmark RESET-RA study has been published in @NatureMedicine! The 12-month outcomes demonstrate durable efficacy & safety of the #SetPointSystem, further validating neuroimmune modulation for #RA. Safety info: spm.care/ISI nature.com/articles/s4159…

Excited to see @SetPointMed co-founder @KevinJTraceyMD recognized for his outstanding work pioneering the science of neuroimmune modulation. An excellent addition to the @AcadofInventors 2025 Class of Fellows! @NorthwellHealth businesswire.com/news/home/2025…

Milestone alert: @CMSGov has granted Transitional Pass-Through (TPT) payment status for the SetPoint System effective Jan 1, 2026. For full safety information, visit spm.care/ISI. See more at: setpointmedical.com/setpoint-medic… #StartActivating #TheSetPointAdvantage #RA

We’re honored that the SetPoint System has been named one of @TIME’s Best Inventions of 2025 in Medical & Healthcare. 🏆 Read about it here: time.com/collections/be… Please see important safety information at spm.care/ISI #TIMEBestInventions #StartActivating #RA

We’re thrilled to see the #SetPointSystem featured on @NPR. The story spotlights Lynn, who found relief after years of debilitating RA pain. Please see important safety information at spm.care/ISI npr.org/2025/09/16/nx-…

Big news today! @NorthwellHealth is the first health system in the nation to provide the recent FDA-approved #SetPointSystem, implanting its first patient on Aug. 22. Read about it: setpointmedical.com/northwell-heal… #SetPointTherapy #RheumatoidArthritis #RheumTwitter #NeuroimmuneModulation

Big ambition takes big investment and audacious leadership -- that's why we're excited to announce today that we've secured $140 million in private financing, and welcomed key new executives to our leadership team and board of directors. Read more: setpointmedical.com/setpoint-medic…

Controlling the immune system and inflammation through stimulating the vagus nerve. FDA approval of an implant for refractory rheumatoid arthritis that is also being studied for various autoimmune diseases. Front page @nytimes great work by @KevinJTraceyMD @SetPointMed nytimes.com/2025/07/31/hea…

We're so pleased to see this coverage of the FDA approval of the #SetPointSystem in the @nytimes! Read the full story to learn more about the life-changing power of neuroimmune modulation: nytimes.com/2025/07/31/hea… Safety info in bio. #Rheumatology #RheumTwitter #MedTwitter

We were honored to have our national surgical PI @RMarkRichardson present RESET-RA results during the Plenary Session at #AANS25. Data presented highlight SetPoint System’s potential as a first-of-its-kind neuroimmune modulation treatment for RA. #TheSetPointAdvantage

Nice story by @NPR about how neuroimmune modulation is unlocking new possibilities for treating autoimmune diseases like #RA. npr.org/sections/shots… #TheSetPointAdvantage The SetPoint System is limited by U.S. law to investigational use only.

We're excited to announce late-breaking data from the RESET-RA study at @ACRheum #ACR24 supporting the SetPoint System's potential as a first-of-its-kind neuroimmune modulation treatment for rheumatoid arthritis (#RA). Learn more in our press release: setpointmedical.com/setpoint-medic…